“abl”的搜索结果

27 个项目

每页

设置降序顺序
  1. KW-2449

    Catalog No. A10508
    Quick View
    FLT3/FGFR/Bcr-Abl/Aurora 抑制剂
    KW-2449是FLT3、ABl、ABl-T315I和Aurora激酶的多激酶抑制剂。 了解更多
  2. XL-228

    Catalog No. A13069
    Quick View
    IGF-1R, Aurora, FGFR, ABL, SRC 抑制剂
    XL228是靶向IGF1R,AURORA激酶,FGFR1-3,ABL和SRC家族激酶的蛋白激酶抑制剂。XL228是一种Aurora A抑制剂(IC50,f3 nmol/L),对ABL1(Ki,5 nmol/L)以及BCR-ABL1 T315I(Ki,1.4 nmol/L)激酶显示出有效的生化活性。 了解更多
  3. Danusertib (PHA-739358)

    Catalog No. A10715
    Quick View
    Aurora 抑制剂
    Danusertib (PHA-739358)是Aurora A/B/C的Aurora激酶抑制剂,在无细胞分析中的IC50为13 nM/79nM/61 nM,对Abl,TrkA,c-RET和FGFR1以及更低的浓度具有中等效力 对Lck,VEGFR2/3,c-Kit,CDK2等有效。 了解更多
  4. Talazoparib tosylate

    Catalog No. A20238
    Quick View
    PARP1/2 inhibitor
    Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1. 了解更多
  5. GeA-69

    Catalog No. A19705
    Quick View
    PARP14 inhibitor
    GeA-69 is a selective, highly cell permeable allosteric inhibitor of poly-adenosine-diphosphate-ribose polymerase 14 (PARP14) targeting macrodomain 2, with a Kd of 2.1 ?M. 了解更多
  6. YF-2

    Catalog No. A21018
    Quick View
    histone acetyltransferase activator
    YF-2 is a highly selective, blood-brain-barrier permeable histone acetyltransferase activator, acetylates H3 in the hippocampus, with EC50s of 2.75 μM, 29.04 μM and 49.31 μM for CBP, PCAF, and GCN5, respectively, shows no effect on HDAC. Anti-cancer and anti-Alzheimer's disease. 了解更多
  7. NMS-P118

    Catalog No. A20994
    Quick View
    PARP-1 Inhibitor
    NMS-P118 is a potent, orally available, and highly selective PARP-1 Inhibitor for cancer therapy. 了解更多
  8. MI-503

    Catalog No. A20975
    Quick View
    menin-mLL interaction inhibitor
    MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction. 了解更多
  9. AZD5153 6-Hydroxy-2-naphthoic acid

    Catalog No. A21852
    Quick View
    BET/BRD4 bromodomain inhibitor
    AZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153. AZD5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor; disrupts BRD4 with an IC50 of 1.7 nM. 了解更多
  10. Tazemetostat hydrobromide

    Catalog No. A21759
    Quick View
    EZH2 inhibitor
    Tazemetostat hydrobromide (EPZ-6438 hydrobromide) is a potent, selective and orally available EZH2 inhibitor. 了解更多
  11. HDAC-IN-7

    Catalog No. A21252
    Quick View
    HDAC1/2/3/10 inhibitor
    HDAC-IN-7 (Chidamide impurity) is an impurity of Chidamide. Chidamide is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor. 了解更多
  12. CCT241736

    Catalog No. A21097
    Quick View
    dual FLT3/Aurora kinase inhibitor
    CCT241736 is a potent and orally bioavailable dual FLT3 and Aurora kinase inhibitor. 了解更多
  13. GDC-0339

    Catalog No. A20920
    Quick View
    Pim kinase inhibitor
    GDC-0339 is a potent, orally bioavailable and well tolerated pan-Pim kinase inhibitor, with Kis of 0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 and Pim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma. 了解更多
  14. Niraparib hydrochloride

    Catalog No. A18018
    Quick View
    PARP1 and PARP2 inhibitor
    Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. 了解更多
  15. Niraparib tosylate

    Catalog No. A16618
    Quick View
    PARP1/PARP2 inhibitor
    Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. 了解更多
  16. Histone Acetyltransferase Inhibitor II

    Catalog No. A12331
    Quick View
    cell permeable p300 inhibitor
    Histone Acetyltransferase Inhibitor II is a potent and cell permeable p300 inhibitor, with an IC50 of 5 ?M; Histone Acetyltransferase Inhibitor II can be used in cancer research. 了解更多
  17. Tofacitinib

    Catalog No. A17252
    Quick View
    JAK3/2/1 inhibitor
    Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively. 了解更多
  18. GS-626510

    Catalog No. A13305
    Quick View
    BET family bromodomains inhibitor
    GS-626510 is a potent, and orally bioavailable BET family bromodomains inhibitor, with Kd values of 0.59-3.2 nM for BRD2/3/4, with IC50 values of 83 nM and 78 nM foe BD1 and BD2, respectively. 了解更多
  19. YUKA1

    Catalog No. A12101
    Quick View
    cell permeable Lysine demethylase 5A (KDM5A) inhibitor
    YUKA1 is a potent and cell permeable Lysine demethylase 5A (KDM5A) inhibitor, with an IC50 of 2.66 μM. 了解更多
  20. CHDI-390576

    Catalog No. A18899
    Quick View
    HDAC inhibitor
    CHDI-390576, a potent, cell permeable and CNS penetrant class IIa histonedeacetylase (HDAC) inhibitor with IC50s of 54 nM, 60 nM, 31 nM, 50 nM for class IIa HDAC4, HDAC5, HDAC7, HDAC9, respectively, shows >500-fold selectivity over class I HDACs (1, 2, 3) and ~150-fold selectivity over HDAC8 and the class IIb HDAC6 isoform. 了解更多
  21. CD235

    Catalog No. A19115
    Quick View
    BET bromodomain inhibitor
    CD235 is a structurally similar analogue of CD161. CD161 is a potent and orally bioavailable BET bromodomain inhibitor. 了解更多
  22. DPM-1001

    Catalog No. A18674
    Quick View
    PTP1B inhibitor
    DPM-1001 is a potent, specific, orally bioavailable and non-competitive inhibitor of protein-tyrosine phosphatase (PTP1B) with an IC50 of 100 nM, an an analog of the specific PTP1B inhibitor trodusquemine (MSI-1436; IC50=600 nM). DPM-1001 has anti-diabetic property. 了解更多
  23. GSK467

    Catalog No. A18807
    Quick View
    KDM5B (JARID1B or PLU1) inhibitor
    GSK467 is a potent and selective inhibitor of KDM5 (also known as JARID1) with a Ki of 10 nM, shows 180-fold selectivity for KDM4C and no measurable inhibitory effects toward KDM6 or other Jumonji family members. GSK467 exploits unique binding modes. 了解更多
  24. GNE-207

    Catalog No. A18844
    Quick View
    CBP bromodomain inhibitor
    GNE-207 is a novel, potent, and orally bioavailable inhibitor of the bromodomain of CBP. GNE-207 has excellent CBP potency (CBP IC50?=?1?nM, MYC EC50?=?18?nM), and it exhibits a good pharmacokinetic profile. 了解更多
  25. Tucidinostat (Chidamide)

    Catalog No. A17861
    Quick View
    HDAC inhibitor
    Tucidinostat is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8 and HDAC11 (IC50s, 733 nM, 432 nM, respectively), and shows no effect on HDAC4/5/6/7/9. 了解更多
  26. NU 9056

    Catalog No. A13378
    Quick View
    KAT5 (Tip60) HAT 抑制剂
    NU9056是一种选择性KAT5(Tip60)HAT抑制剂。对于KAT5,p300,pCAF和GCN5,IC50值分别为<2、60、36和> 100μM。抑制前列腺癌细胞系和蛋白质块中的蛋白质乙酰化。 了解更多
  27. TAK-901

    Catalog No. A11067
    Quick View
    Aurora Kinase A/B 抑制剂
    TAK-901是一种新型Aurora A/B抑制剂,IC50为21 nM/15 nM。它不是细胞JAK2,c-Src或Abl的有效抑制剂。 了解更多

27 个项目

每页

设置降序顺序
Rewards